Hypercalcemia, hypervitaminosis A and 3-epi-25-OH-D3 levels after consumption of an “over the counter” vitamin D remedy. A case report

2012 ◽  
Vol 50 (6) ◽  
pp. 2106-2108 ◽  
Author(s):  
F. Granado-Lorencio ◽  
E. Rubio ◽  
I. Blanco-Navarro ◽  
B. Pérez-Sacristán ◽  
R. Rodríguez-Pena ◽  
...  
2017 ◽  
Author(s):  
Kader Ugur ◽  
Hakan Artas ◽  
Mehmet Balin ◽  
Esra Aykut ◽  
Selcuk Demircan ◽  
...  

2017 ◽  
Author(s):  
S Nur Boysan ◽  
Burcu Altunrende ◽  
Levent Dalar ◽  
M Eren Acik ◽  
I Polat Canpolat ◽  
...  

2020 ◽  
Author(s):  
Jagjit S Soar

he current COVID-19 pandemic now believed to be based on the mutation of the SARS-CoV virus (first reported in 2002) to SARS-CoV-2 emerging in 2019, is naturally causing extreme worry and concern around the world with sometimes mixed and incoherent messages on how to deal with it. There is a plethora of information from previous epidemics caused by other coronaviruses such as severe acute respiratory syndrome, SARS (2002) and Middle East respiratory syndrome MERS (2012) from which we can extrapolate guidance on how to deal with the current pandemic. In the current absence of specific pharmaceutical agents, we propose assessing the extended tools that we already possess in our biological armoury to combat, prevent and control the spread of this virus. Using a set of precise criteria to locate such possible contenders, we conducted literature searches to find compounds that met these criteria. We have now reduced this to a shortlist of three agents that may be the best candidates. We propose vitamin C, vitamin D and Curcumin fit our criteria well. These compounds are widely available to the general public. They are available online and over-the-counter as supplements. Otherwise healthy individuals are safely able to self-administer these agents as a prophylactic to protect themselves and to enhance their immune response. This would be especially desirable for the elderly and at risk groups. These agents can also be used as adjunct therapy, particularly for those who may have early symptoms. This preventative therapy could be implemented whilst awaiting specific pharmaceutical drugs to emerge as a treatment for COVID-19. Our suggested compounds are a highly cost-effective way to potentially reduce the mortality that is regretfully mounting as a result of COVID-19 infection. The biological mode of action and the dosing of these compounds are summarised.


2020 ◽  
Vol 42 (4) ◽  
pp. 394-396
Author(s):  
Vigneshvar Chandrasekaran ◽  
Karthick Subramanian ◽  
Avin Muthuramalingam

PEDIATRICS ◽  
1976 ◽  
Vol 57 (5) ◽  
pp. 794-797
Author(s):  
Matthew H. Connors ◽  
Bagher M. Sheikholislam ◽  
Julian J. Irias

Attempts at management of idiopathic hypoparathyroidism with vitamin D have led to various reports of resistance to therapy,1 different responses to vitamin D preparations,2 and unexplained toxicity.3 We report a patient with idiopathic hypoparathyroidism who was persistently hypocalcemic during ten months of treatment with vitamin D, 150,000 units/day. After voluntary weight reduction he became hypercalcemic on the same dose of vitamin D. We believe that the toxicity in this instance was due to release of stored vitamin D into the circulation. CASE REPORT The patient was referred to the hospital at 12½ years of age because of intracranial calcifications noted on roentgenograms obtained for the evaluation of sinusitis.


2010 ◽  
Vol 2010 ◽  
pp. 1-4
Author(s):  
Abdullah S. AlOmran

A case of steroid-induced osteoporosis-related multiple fractures and dislocations are described after a seizure is reported. Patient had two years history of steroid use with no supplement or antiresorptive therapy. There was a delay in the diagnosis which affected an otherwise good outcome in such situations. It is recommended that patients on steroid should be given calcium, vitamin D, and an antiresorptive. Furthermore, a meticulous clinical examination is required in patients who are on steroids and suffer epileptic seizures to rule out skeletal injury.


Sign in / Sign up

Export Citation Format

Share Document